IGF-1 LR3 Peptide: The Complete Guide - Uses, Mechanism, Dosing, Safety & Research
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic 83-amino-acid analog of native IGF-1, engineered with two structural modifications that dramatically reduce its binding to the proteins that normally neutralize IGF-1 in circulation, extending its half-life to 20-30 hours and increasing its potency approximately 2-3 times over native IGF-1. It is most commonly used in investigational contexts targeting muscle growth, body recomposition, and metabolic research, and has been studied in animal models for Alzheimer's-related amyloid pathology. This guide covers what IGF-1 LR3 does, how it works, what the preclinical research shows, its dosing context, its significant safety considerations, and its current regulatory status.
